Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10752920
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10752581
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
granted -
US 10744116
Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas
granted -
US 10745464
Aldehyde tags, uses thereof in site-specific protein modification
granted -
US 10745453
Compositions and methods for enhancing visual function
granted -
US 10736989
Methods and compositions for stabilizing the myocardium
granted -
US 10738113
Anti-IL-2 antibodies and compositions and uses thereof
granted -
US 10729895
Active agent delivery devices and methods of using the same
granted -
US 10729668
Ketobutyrate compounds and compositions for treating age-related symptoms and diseases
granted -
US 10729747
Methods and compositions for modulating myofibroblast activities
granted -
US 10729788
Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine
granted -
US 10730848
Protective molecules against anthrax toxin
granted -
US 10722523
Chemoimmunotherapy for epithelial cancer
granted -
US 10722475
Stealth nanocapsules for protein delivery
granted -
US 10723737
Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
granted -
US 10722540
Microfluidic device and method for shear stress-induced transformation of cells
granted -
US 10711312
Methods for immunotherapy-based treatment and assessment of cancer
granted -
US 10709813
Solubilization of antigen components for removal from tissues
granted -
US 10709739
Method for chemoselection
granted -
US 10711292
Method for promoting the synthesis of collagen and proteoglycan in chondrocytes
granted -
US 10702474
Fusogenic liposome-coated porous silicon nanoparticles
granted -
US 10702506
Small molecule inhibitors of pendrin ion exchange and pharmaceutical compositions
granted -
US 10702498
MU opioid receptor modulators
granted -
US 10702532
Nucleotide analogs
granted